Related Experiment Video
Updated: May 22, 2026

Using Inducible Osteoblastic Lineage-Specific Stat3 Knockout Mice to Study Alveolar Bone Remodeling During Orthodontic Tooth Movement
Published on: July 21, 2023
Transgenic mice for a tamoxifen-induced, conditional expression of the Cre recombinase in osteoclasts
Maria Arantzazu Sanchez-Fernandez1, Silvia Sbacchi, Miguel Correa-Tapia
1Biotechnology Center, Dresden University of Technology, Tatzberg, Dresden, Germany.
Background:
Studies on osteoclasts, the bone resorbing cells, have remained limited due to the lack of transgenic mice allowing the conditional knockout of genes in osteoclasts at any time during development or adulthood.
Methodology/Principal Finding:
We report here on the generation of transgenic mice which specifically express a tamoxifen-inducible Cre recombinase in osteoclasts. These mice, generated on C57BL/6 and FVB background, express a fusion Cre recombinase-ERT2 protein whose expression is driven by the promoter of cathepsin K (CtsK), a gene highly expressed in osteoclasts. We tested the cellular specificity of Cre activity in CtsKCreERT2 strains by breeding with Rosa26LacZ reporter mice. PCR and histological analyses of the CtsKCreERT2LacZ positive adult mice and E17.5 embryos show that Cre activity is restricted largely to bone tissue. In vitro, primary osteoclasts derived from the bone marrow of CtsKCreERT2+/-LacZ+/- adult mice show a Cre-dependent β-galactosidase activity after tamoxifen stimulation.
Conclusions/Significance:
We have generated transgenic lines that enable the tamoxifen-induced, conditional deletion of loxP-flanked genes in osteoclasts, thus circumventing embryonic and postnatal gene lethality and avoiding gene deletion in other cell types. Such CtsKCreERT2 mice provide a convenient tool to study in vivo the different facets of osteoclast function in bone physiology during different developmental stages and adulthood of mice.
Insights
Researchers created new transgenic mice for studying osteoclasts (bone-resorbing cells). These mice allow conditional gene deletion in osteoclasts using tamoxifen, aiding bone research.
Area of Science:
- Osteoclast Biology
- Genetics
- Mouse Models
Background:
- Studying osteoclasts, crucial for bone resorption, has been challenging.
- Lack of tools for conditional gene manipulation in osteoclasts limits research.
Purpose of the Study:
- To develop a transgenic mouse model for conditional gene knockout in osteoclasts.
- To enable temporal and cell-specific gene deletion in osteoclasts.
Main Methods:
- Generated transgenic mice expressing tamoxifen-inducible Cre recombinase under the cathepsin K (CtsK) promoter.
- Utilized Rosa26LacZ reporter mice to assess Cre activity specificity.
- Performed PCR and histological analyses on embryos and adult mice.
Main Results:
- Cre activity was confirmed to be largely restricted to bone tissue in CtsKCreERT2 mice.
- In vitro studies showed tamoxifen-inducible Cre-dependent beta-galactosidase activity in primary osteoclasts.
- Demonstrated successful generation of mice for conditional gene manipulation.
Conclusions:
- Developed CtsKCreERT2 transgenic mice for tamoxifen-inducible, conditional gene deletion in osteoclasts.
- This tool circumvents issues like embryonic lethality and off-target gene deletion.
- Enables in vivo study of osteoclast function across developmental stages and adulthood.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
In-vitro Mutagenesis

